Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RelieVR (now operating as Reducept) is a Dutch digital health company specializing in virtual reality (VR) therapeutics for chronic pain management. Founded in 2018 and based in Leeuwarden, the company developed the 'Reducept' platform, which integrates immersive VR technology with cognitive behavioral therapy (CBT) and neuroscience-based education. The platform enables patients to visualize their pain within a virtual representation of the human body, allowing them to apply psychological techniques to manage pain signals in a gamified environment. This non-pharmacological approach is designed to train the brain to reduce pain intensity and improve quality of life. Reducept is utilized by healthcare professionals in clinical settings and is also available for at-home use by patients. The company has received international recognition, including the World Summit Award, for its innovative approach to digital therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RelieVR.